Name: Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scIgG)
SKU: SCIGG-175
Rating: 5 (1 reviews)

Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-IL17 and anti-TNF IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Rheumatoid arthritis (RA); Plaque psoriasis therapy.

Datasheet INQUIRY

Specifications

Targets

IL17 & TNF

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Rheumatoid arthritis (RA); Plaque psoriasis

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

IL17

Gene ID

3605

UniProt ID

Q16552

Alternative Names

IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)

Target 2

TNF

Gene ID

7124

UniProt ID

P01375

Alternative Names

TNF; tumor necrosis factor; DIF; TNFA; TNFSF2; TNF-alpha; TNFα; cachectin; APC1 protein; TNF, monocyte-derived; TNF-α; TNF, macrophage-derived; tumor necrosis factor-alpha; tumor necrosis factor ligand superfamily member 2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scIgG) (SCIGG-175). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scIgG) (CAT#: SCIGG-175)

Specifications

Targets

Customer Reviews and Q&As